Efficacy and Safety in Patients with Lenalidomide-Refractory Multiple Myeloma after 1-3 Prior Lines Who Received a Single Infusion of Ciltacabtagene Autoleucel As Study Treatment in the Phase 3 CARTITUDE-4 TrialM. Hasib Sidiqi,Paolo Corradini,Duncan Purtill,Hermann Einsele,Binod Dhakal,Lionel Karlin,Salomon Manier,Shinsuke Iida,Sebastian Giebel,Simon J. Harrison,Brea Lipe,Abdullah Khan,Jordan M. Schecter,Carolyn Chang Jackson,Tzu-Min Yeh,Arnob Banerjee,William Deraedt,Nikoletta Lendvai, Carolina Lonardi,Ana Slaughter,Katherine Li,Diana Chen, Jane Gilbert,Tito Roccia, Man Zhao,Nitin Patel,Erika Florendo, Mythili Koneru, Octavio Costa Filho,Dong Geng,Jesus San Miguel,Kwee YongBLOOD(2023)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要